The CCF broadens its certification process guidelines to enable more CDMA vendors to benefit from standardized certification
SAN DIEGO, September 27, 2010 - Amira Pharmaceuticals, Inc. announced today that it has submitted an
Investigational New Drug (IND) application to the US Food and Drug
Administration (FDA) for AM152, a novel LPA1 antagonist. If accepted, the IND
will enable Amira to begin Phase 1 safety studies with the compound in
healthy subjects.
Telefonica Moviles Demonstrates the Fastest Download Speed on Commercial Dual-Carrier HSPA+ Network with Novatel Wireless' Ovation MC545
Bioartificial Liver Trial Now at Halfway Point
SAN DIEGO, September 16, 2010 - Vital Therapies, Inc., (VTI) is pleased to announce that the first
subject has been enrolled at National Guard Hospital in Riyadh, Kingdom of
Saudi Arabia (K.S.A.) in the further expansion of its SILVER (Stabilization
In LiVER Failure) clinical trial to the Middle East. The trial is evaluating
whether VTI's biological cellular therapy product, ELAD(R), can prevent
deterioration of liver function and improve the survival of subjects with
acute-on-chronic liver failure (ACLF).
SAN DIEGO, September 16, 2010 - In the news release, Vital Therapies Expands SILVER Trial to Saudi
Arabia, issued earlier today by Vital Therapies, Inc. over PR Newswire, we
are advised by the company that the there are multiple changes to the
release as originally issued inadvertently.
Complete, corrected release follows:
More News
- Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotech's Annual Fierce 15
- Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients
- Prodesse ProFAST(TM)+ Assay Receives European CE Mark
- New Intra-Nasal Cooling System May Improve Survival When Initiated Soon After Cardiac Arrest
- Qualcomm Announces Third Quarter Fiscal 2010 Results
- Visage Imaging Releases Amira 5.3
- Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program
- APS Technology and Zebra Enterprise Solutions Partner to Increase Gate Velocity and Security for Gulf Stevedoring
- Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
- Sangart, Inc. Completes Enrollment in Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients
- Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
- Novatel Wireless Introduces Its LTE Embedded Modules Portfolio
- Novatel Wireless MiFi Honored With Meffys Award for Best Mobile Connected Device
- Anametrix Extends Global Distribution of Cloud-based Business Analytics Technology
- Carlos Slim Health Institute and West Wireless Health Institute Partner on Wireless Health Initiatives in U.S., Mexico and Throughout Latin America
- Fallbrook Technologies Inc. Announces Agreement With Chengdu Bus Company
- US$25 Million Commitment to the West Wireless Health Institute Brings Total Funding from Gary and Mary West Foundation to Nearly US$100 Million Since Institute's Inception in March 2009
- CareFusion, Cisco and Medtronic to Collaborate With West Wireless Health Institute on Technology and Educational Initiatives
- Qualcomm Makes Strategic Investment in Anteryon
- Cherple(R) 1.5 Leading the Pack With Free SMS Texting From the Internet to Any U.S. Cell Phone
- Bioartificial Human Liver Therapy Trial Progressing
- Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom
- Volcano Announces Plans to Introduce Multiple New Products at EuroPCR 2010
- West Wireless Health Institute and GE Healthcare to Collaborate on Technology and Educational Initiatives
- Novatel Wireless Selects PocketGear to Power MiFi App Store
- Anti-Fibrotic Data from Amira Pharmaceuticals' LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
- PROGENSA(R) PCA3 Assay Can Help Predict Outcome of Initial Prostate Biopsies, According to Study Presented at Leading Urology Meeting
- Amira Pharmaceuticals Announces Patent Grant in United Kingdom
- Qualcomm Announces Second Quarter Fiscal 2010 Results
- Accumetrics, Inc. Announces Completion of GRAVITAS Trial Enrollment
- Novatel Wireless MiFi Wins 2010 Mobile News Awards
- West Wireless Health Institute Names Dr. Joseph Smith to Serve as Chief Medical and Science Officer
- Qualcomm Raises Financial Guidance for the Second Fiscal Quarter of 2010
- DivX Releases New DivX Plus(TM) Software Package for Easy Playback of HD Video
- Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
- Helix Wind Announces Change in Executive Leadership and Board of Directors
- West Wireless Health Institute Names Donald Casey to Serve as its CEO
- PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented at Leading Medical Meeting Confirm
- RAYSPAN(R) Announces Breakthrough Antenna Solution for LTE Devices
- Novatel Wireless MiFi Intelligent Mobile Hotspot Wins GSMA Global Mobile Award for Best Mobile Connected Device
- Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
- SmartDrive Quarterly Distracted Driving Index Declines 12% and Now Stands at 15.8%
- Qualcomm Announces First Quarter Fiscal 2010 Results
- Accumetrics Achieves ISO 13485 Medical Device Certification
- Amira Pharmaceuticals Achieves Development Milestone Related to FLAP Inhibitor Program
- Rayspan Metamaterial Antennas Reduce Handset Radiation Exposure, Accelerate Testing & Reduce Time to Market
- SAP(R) and Security Weaver(TM) Settle Lawsuit
- SmartDrive Systems Secures US$25M in Venture Funding; Names Dave Vucina Chairman of the Board
- Accumetrics Closes 2009 with Positive Outlook
- SmartDrive Releases New Event Player, Makes Driver Coaching Easier and More Effective
- Reaction Design Opens European Sales Office and Appoints Christopher Riley as European Sales Director
- Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211
- Volkswagen Aligns with Model Fuels Consortium-II
- VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
- Emerald Monkey Eco-Luxe Resort & Residences Receives Eight Prestigious Property Awards
- Prodesse's ProFlu-ST(TM) Assay Receives European CE Mark
- Panoramic Power Wins Qualcomm Ventures QPrize Business Plan Competition
- Qualcomm Announces Fourth Quarter and Fiscal 2009 Results
- Pannon Launches Novatel Wireless MiFi 2352
- First Intra-Arrest Cooling Study Chosen for AHA Scientific Sessions Late Breaking Presentation
- RAYSPAN’s Metamaterial Air Interface Selected for LG Electronics’ New Chocolate Phone
- Acision Works With Partners Across the Global Communications Industry to Create and Market New Applications and Services
- Ideaworks Labs Announces Airplay SDK Now Enables Single-Click Deployment to all Android and iPhone Devices
- Novarra Partners Enjoy Boom in Mobile Internet Users, Data, and Video Consumption
- Accumetrics Announces US$16.5M in New Capital Financing
- ResMed Acquires Laboratoires Narval
- Vital Therapies Initiates Liver Stabilization Trial
- RAYSPAN Ships 20 Millionth Metamaterial Antenna!
- RAYSPAN’s Metamaterial Antennas Provide the Extended Range and WiFi Performance in NETGEAR’s Ultimate Networking Machine
- Accumetrics, Inc. Forms Partnership With Grifols as Its Distributor in Spain, Portugal and Chile
- SmartDrive Study Quantifies Commercial Driver Distraction, Presenting Significant Risk of Crash
- CDMA Certification Forum Achieves ISO/IEC Guide 65 Accreditation
- Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
- RAYSPAN Corporation Announces Grant of Fundamental Metamaterial Air Interface Patent
- Vertica Analytic Database 3.5 Broadens Reach with Added FlexStore Architecture, Incorporates MapReduce Integration
- Rayspan Raises US$12.5 million in Series B Financing from Khosla Ventures & Sequoia Capital
- Qualcomm Announces Third Quarter Fiscal 2009 Results
- Accumetrics’ VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient’s Response to Newly-Approved Prasugrel (Effient(R))
- Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
- RoyaltyShare Expands Services for UK Record Labels With Support for Processing of MCPS Royalties
- Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
- Qualcomm Raises Financial Guidance for the Third Fiscal Quarter of 2009
- Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
- Video: Qualcomm MEMS Technologies and Foxlink Commence Operations at Dedicated mirasol Display Fabrication Facility
- Pure Play Music Signs Deal to Revolutionize the Advertising Industry With the World’s Leading Online Music Placement Company, Ricall
- Pure Play Music and WSA Distributing Partner to Eliminate the Need for a mp3 Player
- Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
- Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
- Qualcomm Announces Second Quarter Fiscal 2009 Results
- Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
- Psylin Neurosciences Commences Development of Compound for Depression
- Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist
- Gen-Probe Completes Acquisition of Tepnel Life Sciences
- Metamaterial Pioneer Rayspan to Present and Exhibit Its WLAN and WWAN Applications at the third European Conference on Antennas and Propagation (EuCAP 2009)
- Metamaterial Pioneer Rayspan to Present IEEE Distinguished Lecture and Exhibit Its WLAN and WWAN Applications at the Third European Conference on Antennas and Propagation (EuCAP 2009)
